Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Statin-associated muscle symptoms in coronary patients: design of a randomized study.

Munkhaugen J, Vethe NT, Fagerland MW, Dammen T, Perk J, Gjertsen E, Otterstad JE, Gullestad L, Bergan S, Husebye E.

Scand Cardiovasc J. 2019 Jun;53(3):162-168. doi: 10.1080/14017431.2019.1612085. Epub 2019 May 13.

PMID:
31030568
2.

ESC Advocacy works!

Badimon L, Perk J.

Eur Heart J. 2019 Apr 7;40(14):1097-1098. doi: 10.1093/eurheartj/ehz143. No abstract available.

PMID:
30955037
3.

Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event.

Peersen K, Otterstad JE, Sverre E, Perk J, Gullestad L, Moum T, Dammen T, Munkhaugen J.

J Cardiopulm Rehabil Prev. 2019 Jan 31. doi: 10.1097/HCR.0000000000000399. [Epub ahead of print]

PMID:
30720643
4.

Maintaining physical activity in patients after acute coronary syndromes, the challenge remains.

Perk J.

Eur J Prev Cardiol. 2019 Jan 31:2047487319826383. doi: 10.1177/2047487319826383. [Epub ahead of print] No abstract available.

PMID:
30700160
5.

Too much of a good thing?

Perk J.

Eur Heart J. 2019 Jan 21;40(4):334. doi: 10.1093/eurheartj/ehy853. No abstract available.

PMID:
30668701
6.

Comparison of the rates of stroke and acute coronary events in northern France.

Perk J.

Eur J Prev Cardiol. 2018 Sep;25(14):1532-1533. doi: 10.1177/2047487318794246. Epub 2018 Aug 14. No abstract available.

PMID:
30103627
7.

Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.

Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T.

BMC Cardiovasc Disord. 2018 Aug 3;18(1):160. doi: 10.1186/s12872-018-0896-z.

8.

Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study.

Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Nuevo J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C, Halcox JP.

Int J Cardiol. 2018 Feb 15;253:167-173. doi: 10.1016/j.ijcard.2017.10.045.

PMID:
29306459
9.

Optimal blood pressure control after coronary events: the challenge remains.

Sverre E, Peersen K, Otterstad JE, Gullestad L, Perk J, Gjertsen E, Moum T, Husebye E, Dammen T, Munkhaugen J.

J Am Soc Hypertens. 2017 Dec;11(12):823-830. doi: 10.1016/j.jash.2017.10.007. Epub 2017 Oct 28.

PMID:
29128603
10.

[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM.

G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821. Italian. No abstract available.

PMID:
28714997
11.

The role of cardiac rehabilitation in secondary prevention after coronary events.

Peersen K, Munkhaugen J, Gullestad L, Liodden T, Moum T, Dammen T, Perk J, Otterstad JE.

Eur J Prev Cardiol. 2017 Sep;24(13):1360-1368. doi: 10.1177/2047487317719355. Epub 2017 Jun 30.

PMID:
28664773
12.

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.

Halcox JP, Banegas JR, Roy C, Dallongeville J, De Backer G, Guallar E, Perk J, Hajage D, Henriksson KM, Borghi C.

BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5.

13.

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.

Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E.

Eur J Prev Cardiol. 2017 Jun;24(9):981-989. doi: 10.1177/2047487317693134. Epub 2017 Feb 14.

PMID:
28196429
14.

The 2016 version of the European Guidelines on Cardiovascular Prevention.

Perk J.

Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):9-10. doi: 10.1093/ehjcvp/pvw030. No abstract available.

PMID:
28062656
15.

[New care model for prevention after acute coronary artery disease].

Perk J, Burell G, Hambraeus K, Henriksson C, Carlsson R, Johansson P.

Lakartidningen. 2016 Dec 19;113. pii: EA74. Swedish. No abstract available.

16.

[A healthy lifestyle in focus of new guidelines].

Perk J, Agewall S, Kiessling A.

Lakartidningen. 2016 Oct 20;113. pii: D7HM. Swedish. No abstract available.

17.

An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014.

Karjalainen T, Adiels M, Björck L, Cooney MT, Graham I, Perk J, Rosengren A, Söderberg S, Eliasson M.

Eur J Prev Cardiol. 2017 Jan;24(1):103-110. Epub 2016 Oct 5.

PMID:
27708071
18.

2016 European Guidelines on cardiovascular disease prevention in clinical practice.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Richard Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Monique Verschuren WM.

Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939. doi: 10.1016/j.rec.2016.09.009. English, Spanish. No abstract available.

PMID:
27692125
19.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members:, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Verschuren WMM.

Atherosclerosis. 2016 Sep;252:207-274. doi: 10.1016/j.atherosclerosis.2016.05.037. No abstract available.

PMID:
27664503
20.

[2016 European Guidelines on cardiovascular disease prevention in clinical practice].

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Binno S.

Kardiol Pol. 2016;74(9):821-936. doi: 10.5603/KP.2016.0120. Polish. No abstract available.

21.

The association between blood pressure and lipid levels in Europe: European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice.

Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C, Halcox JP.

J Hypertens. 2016 Nov;34(11):2155-63. doi: 10.1097/HJH.0000000000001078.

PMID:
27512970
22.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Additional Contributor: Simone Binno (Italy); Document Reviewers:, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL.

Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 2016 Jun 27. No abstract available.

PMID:
27353126
23.

Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study.

Borghi C, Tubach F, De Backer G, Dallongeville J, Guallar E, Medina J, Perk J, Roy C, Banegas JR, Rodriguez-Artalejo F, Halcox JP.

Int J Cardiol. 2016 Sep 1;218:83-88. doi: 10.1016/j.ijcard.2016.05.044. Epub 2016 May 13.

PMID:
27232917
24.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group.

Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. No abstract available.

25.

A systematic review of studies in the contributions of the work environment to ischaemic heart disease development.

Theorell T, Jood K, Järvholm LS, Vingård E, Perk J, Östergren PO, Hall C.

Eur J Public Health. 2016 Jun;26(3):470-7. doi: 10.1093/eurpub/ckw025. Epub 2016 Mar 31. Review.

26.

High-grade carotid artery stenosis: A forgotten area in cardiovascular risk management.

Good E, Länne T, Wilhelm E, Perk J, Jaarsma T, de Muinck E.

Eur J Prev Cardiol. 2016 Sep;23(13):1453-60. doi: 10.1177/2047487316632629. Epub 2016 Feb 15.

27.

The role of medical and psychosocial factors for unfavourable coronary risk factor control.

Munkhaugen J, Sverre E, Peersen K, Gjertsen E, Gullestad L, Moum T, Otterstad JE, Perk J, Husebye E, Dammen T.

Scand Cardiovasc J. 2016;50(1):1-8. doi: 10.3109/14017431.2015.1111408. Epub 2015 Nov 17.

PMID:
26488672
28.

The MacNew Heart Disease Health-Related Quality of Life Questionnaire: A Scandinavian Validation Study.

Alphin S, Höfer S, Perk J, Slørdahl S, Zwisler AO, Oldridge N.

Soc Indic Res. 2015;122(2):519-537. Epub 2014 Jul 24.

29.

EACPR country of the month initiative: Sweden.

Kiessling A, Hambraeus K, Held C, Norhammar A, Perk J.

Eur Heart J. 2015 Apr 21;36(16):951-2. No abstract available.

PMID:
26082959
30.

[Serious deficiencies in information to coronary patients after balloon angioplasty. Patients underestimate the importance of life habits, as shown in survey study].

Perk J, Burell G, Carlsson R, Hambraeus K, Johansson P, Lisspers J.

Lakartidningen. 2014 Oct 15-21;111(42):1835-7. Swedish. No abstract available.

31.

Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

Halcox JP, Tubach F, Lopez-Garcia E, De Backer G, Borghi C, Dallongeville J, Guallar E, Medina J, Perk J, Sazova O, Sweet S, Roy C, Banegas JR, Rodriguez-Artalejo F.

PLoS One. 2015 Feb 18;10(2):e0115270. doi: 10.1371/journal.pone.0115270. eCollection 2015.

32.

The 10-year anniversary of the European Association for Cardiovascular Prevention and Rehabilitation: achievements and challenges.

Perk J, DeBacker G, Saner H, Wood D, Giannuzzi P, Gielen S, Pelloiccia A.

Eur J Prev Cardiol. 2015 Oct;22(10):1340-5. doi: 10.1177/2047487314549515. Epub 2014 Sep 10.

PMID:
25208907
33.

Health-related quality of life in European women following myocardial infarction: a cross-sectional study.

Lidell E, Höfer S, Saner H, Perk J, Hildingh C, Oldridge N.

Eur J Cardiovasc Nurs. 2015 Aug;14(4):326-33. doi: 10.1177/1474515114535330. Epub 2014 May 12.

PMID:
24821717
34.

Prevention of cardiovascular disease: new guidelines, new tools, but challenges remain.

Perk J, Graham I, De Backer G.

Heart. 2014 May;100(9):675-7. doi: 10.1136/heartjnl-2014-305650. Epub 2014 Mar 25. No abstract available.

PMID:
24667311
35.

C-reactive protein levels in patients at cardiovascular risk: EURIKA study.

Halcox JP, Roy C, Tubach F, Banegas JR, Dallongeville J, De Backer G, Guallar E, Sazova O, Medina J, Perk J, Steg PG, Rodríguez-Artalejo F, Borghi C.

BMC Cardiovasc Disord. 2014 Feb 24;14:25. doi: 10.1186/1471-2261-14-25.

36.

Study of Patient Information after percutaneous Coronary Intervention (SPICI): should prevention programmes become more effective?

Perk J, Hambraeus K, Burell G, Carlsson R, Johansson P, Lisspers J.

EuroIntervention. 2015 Mar 22;10(11):e1-7. doi: 10.4244/EIJV10I11A223.

37.

Strengths and weaknesses of working with the Global Trigger Tool method for retrospective record review: focus group interviews with team members.

Schildmeijer K, Nilsson L, Perk J, Arestedt K, Nilsson G.

BMJ Open. 2013 Sep 24;3(9):e003131. doi: 10.1136/bmjopen-2013-003131.

38.

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG.

Eur Heart J. 2013 Oct;34(39):3035-87. doi: 10.1093/eurheartj/eht108. Epub 2013 Aug 30. No abstract available. Erratum in: Eur Heart J. 2014 Jul 14;35(27):1824.

PMID:
23996285
39.

Retrospective record review in proactive patient safety work - identification of no-harm incidents.

Schildmeijer K, Unbeck M, Muren O, Perk J, Pukk Härenstam K, Nilsson L.

BMC Health Serv Res. 2013 Jul 22;13:282. doi: 10.1186/1472-6963-13-282.

40.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA.

Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14. No abstract available.

PMID:
23771844
41.

[Wanted: Politics against heart attacks].

Agewall S, Rydén L, Perk J, Rosengren A, Boman K, Hellénius ML, Ros I.

Lakartidningen. 2013 Mar 26-Apr 9;110(13-14):664. Swedish. No abstract available.

PMID:
23634619
42.

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germanò G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Comitato per Linee Guida Pratiche (CPG) dell'ESC.

G Ital Cardiol (Rome). 2013 May;14(5):328-92. doi: 10.1714/1264.13964. Italian. No abstract available.

PMID:
23612326
43.

The assessment of adverse events in medical care; lack of consistency between experienced teams using the Global Trigger Tool’.

Schildmeijer KG, Nilsson L, Arestedt K, Perk J.

BMJ Qual Saf. 2013 Mar;22(3):271-2. doi: 10.1136/bmjqs-2012-001587. No abstract available.

PMID:
23424260
44.

Perspective: The power of disease prevention.

Perk J.

Nature. 2013 Jan 31;493(7434):S6. doi: 10.1038/493S6a. No abstract available.

PMID:
23364770
45.

[Cardiovascular disease in Europe is not only a success story].

Perk J.

Lakartidningen. 2012 Nov 21-27;109(47):2143. Swedish. No abstract available.

PMID:
23330476
46.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Eur J Prev Cardiol. 2013 Feb;20(1):6-8. doi: 10.1177/2047487312464001. No abstract available.

PMID:
23258929
47.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Atherosclerosis. 2013 Jan;226(1):299-300. doi: 10.1016/j.atherosclerosis.2012.10.042. Epub 2012 Oct 17. No abstract available.

PMID:
23102598
48.

European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Int J Behav Med. 2012 Dec;19(4):403-88. doi: 10.1007/s12529-012-9242-5. No abstract available.

PMID:
23093473
49.

[European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)].

Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne Mikko, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Avrupa Kardiyoloji Derneği ile Klinik Uygulamada; Kardiyovasküler Hastaliklardan Korunma Üzerinde Çalişan Diğer Derneklerin Beşinci Birleşik Görev Grubu (dokuz derneğin temsilcileri ve davet edilmiş uzmanlardan oluşmaktadir; Avrupa Kardiyovasküler Korunma and Rehabilitasyon (EACPR); özel Katkisi ile geliştirilmiştir.

Turk Kardiyol Dern Ars. 2012 Oct;40 Suppl 3:1-76. Turkish. No abstract available.

50.

[New European guidelines on cardiovascular disease prevention].

Perk J.

Lakartidningen. 2012 Aug 22-Sep 4;109(34-35):1463. Swedish. No abstract available.

PMID:
22993894

Supplemental Content

Support Center